Patient Care

This page includes news coverage of various aspects of patient healthcare, including new technology innovations, what is working, what is not, personalized medicine and remote and telemedicine delivery. Find specific news in the areas of Care Delivery, Digital Transformation, Precision Medicine, Remote Monitoring and Telehealth.

RSS icon
Quantum computer superconductivity

Moderna throws in with IBM over quantum computing, generative AI for healthcare

Fresh off its success using AI to develop a blockbuster COVID vaccine, up-and-coming biotech player Moderna (founded 2010) has won the confidence of 112-year-old Big Blue as a strategic partner.

Thumbnail

Supreme Court upholds full access to abortion pill

The Supreme Court issued a stay on April 21 that keeps mifepristone on the market without restrictions––for now.

Infusion system recalled for possible leaks after multiple complaints

The recall includes more than 1,500 devices distributed to customers from October 2021 to January 2023. 

Thumbnail

OTC Narcan will cost less than $50

The drug's manufacturer said it is working with retailers to get the drug on U.S. shelves and online for purchase by late summer.

bullish investments in healthcare AI

What healthcare AI investors have been saying at HIMSS23

If great power obligates its wielder to exercise great responsibility, those advancing AI in healthcare are up to their necks in duty.

GE Healthcare solution, billed as a 'unified approach to patient monitoring,' gains FDA clearance

GE Healthcare received clearance from the U.S. Food and Drug Administration (FDA) for its patient monitoring platform, Carescape Canvas.

Thumbnail

Supreme Court delays final decision on abortion pill for 2 more days

A common abortion pill, mifepristone, is still in grave danger of being pulled off the market. 

Thumbnail

CVS Health names former Humana exec the new president of Aetna

Brian Kane has been appointed as executive vice president and president of Aetna. 

Displaying 489 - 496 of 5132

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup